strut semaglutide Microdose Semaglutide

Novo Nordisk, Eli Lilly, Pfizer, Amgen and others are all competing to develop stronger and more convenient weight loss drugs Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to crown any winners in the race for the next generation of anti-obesity treatments

Initial findings indicate it aids in weight loss and blood sugar control over the course of months

Tirzepatide (marketed as Zepbound for weight management and Mounjaro for type 2 diabetes in the UK) is a dual GIP/GLP-1 receptor agonist that has shown similar side effect profiles in clinical trials, including reports of dizziness

By expanding access through leading telehealth providers and digital care platforms, we are helping to connect more people with our FDA-approved medicines, which have been evaluated for safety and efficacy